 |
|
|
| |
CSF ART Exposure, Population Pharmacokinetic
Approaches to Standardize Antiviral Exposure in the Cerebrospinal Fluid
|
| |
| |
CROI 2024 March 3-6 Denver
Sean N. Avedissian1, Ying Mu1, Caitlin McCarthy2, Ronald J. Bosch2, Serena Spudich3, Rajesh T. Gandhi4, Deborah K. McMahon5, Joshua C. Cyktor5, Joseph J. Eron6, John W. Mellors5, Courtney V. Fletcher1
1University of Nebraska Medical Center, Omaha, NE, 2Harvard T.H. Chan School of Public Health, Boston, MA, 3Yale University, New Haven, CT, 4Massachusetts General Hospital, Boston, MA, 5University of Pittsburgh, Pittsburgh, PA, 6University of North Carolina, Chapel Hill, NC
Abbreviations: TFV, tenofovir disoproxil fumarate; FTC, emtricitabine; EFV, efavirenz; DTG, dolutegravir; RAL, raltegravir; EVG, elvitegravir; ATV, atazanavir; DRV, darunavir/ritonavir; CSF, cerebrospinal fluid.
|
| |
|
|
|
|
|
